Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
Journal of Hepatology
|
May 30, 2013
The metabolomic window into hepatobiliary disease
Diren Beyoğlu, Jeffrey R Idle
Hepatology (Baltimore, Md.)
|
September 7, 2013
Painting the liver with lasers: the future of liver histology?
Diren Beyoğlu, Jeffrey R Idle
Biochemical Pharmacology
|
August 23, 2022
The gut microbiota - A vehicle for the prevention and treatment of hepatocellular carcinoma
Diren Beyoğlu, Jeffrey R Idle
Cancers
|
July 2, 2021
Metabolic Rewiring and the Characterization of Oncometabolites
Diren Beyoğlu, Jeffrey R Idle
Biochemical Pharmacology
|
September 1, 2012
Metabolomics and its potential in drug development
Diren Beyoğlu, Jeffrey R Idle
International Journal of Molecular Sciences
|
April 17, 2025
The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Jeffrey R Idle
Biomolecules
|
June 26, 2026
The Gut-Lung Microbiome Crosstalk and Pulmonary Disease
Diren Beyoğlu, Jeffrey R Idle
Biochemical Pharmacology
|
July 26, 2020
Metabolomic insights into the mode of action of natural products in the treatment of liver disease
Diren Beyoğlu, Jeffrey R Idle
Pharmacology & Therapeutics
|
May 16, 2012
The glycine deportation system and its pharmacological consequences
Diren Beyoğlu, Jeffrey R Idle
Metabolites
|
February 5, 2020
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R Idle
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
Journal of Hepatology
|
May 30, 2013
The metabolomic window into hepatobiliary disease
Diren Beyoğlu, Jeffrey R Idle
Hepatology (Baltimore, Md.)
|
September 7, 2013
Painting the liver with lasers: the future of liver histology?
Diren Beyoğlu, Jeffrey R Idle
Biochemical Pharmacology
|
August 23, 2022
The gut microbiota - A vehicle for the prevention and treatment of hepatocellular carcinoma
Diren Beyoğlu, Jeffrey R Idle
Cancers
|
July 2, 2021
Metabolic Rewiring and the Characterization of Oncometabolites
Diren Beyoğlu, Jeffrey R Idle
Biochemical Pharmacology
|
September 1, 2012
Metabolomics and its potential in drug development
Diren Beyoğlu, Jeffrey R Idle
International Journal of Molecular Sciences
|
April 17, 2025
The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Jeffrey R Idle
Biomolecules
|
June 26, 2026
The Gut-Lung Microbiome Crosstalk and Pulmonary Disease
Diren Beyoğlu, Jeffrey R Idle
Biochemical Pharmacology
|
July 26, 2020
Metabolomic insights into the mode of action of natural products in the treatment of liver disease
Diren Beyoğlu, Jeffrey R Idle
Pharmacology & Therapeutics
|
May 16, 2012
The glycine deportation system and its pharmacological consequences
Diren Beyoğlu, Jeffrey R Idle
Metabolites
|
February 5, 2020
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R Idle
Page
of 10